REQUEST A DEMO
Total
USD $0.00
Search more companies

Cooperativa Epsifarma (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cooperativa Epsifarma Profile Updated: March 19, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Cooperativa Epsifarma is a company in Colombia, with a head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on March 13, 2006. There are currently 1,115 (2018) people employed by Cooperativa Epsifarma. From the latest financial highlights, Cooperativa Epsifarma reported a net sales revenue increase of 42.23% in 2025. Its’ total assets recorded a negative growth of 1.79%. The enterprise’s net profit margin decreased by 302.5% in 2025.

Headquarters
Aut Norte 108 27 To 3 P 4
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Cooperativa Epsifarma report to view the information.

Website: http://www.epsifarma.com.co/

Basic Information
Total Employees:
Purchase the Cooperativa Epsifarma report to view the information.
Registered Capital:
Purchase the Cooperativa Epsifarma report to view the information.
Financial Auditors:
Purchase the Cooperativa Epsifarma report to view the information.
Incorporation Date:
March 13, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Subsidiaries
Intelpharma S.A.S.
Company Performance
Financial values in the chart are available after Cooperativa Epsifarma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
42.23%
Total Operating Revenue
-40.49%
Operating Profit
-52.1%
EBITDA
-52.1%
Net Profit/Loss for the Period
-29.22%
Total Assets
-1.79%
Total Equity
-0.88%
Operating Profit Margin
-201.28%
Net Profit Margin
-302.5%
Return on Equity (ROE)
0.56%
Debt / Equity
16%
Quick Ratio
-3.15%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?